1340 studies found for:    "Liver Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting PET/CT-Assessment of Liver Tumor Ablation
Conditions: Liver Tumor;   Liver Neoplasms
Interventions: Radiation: N-13 ammonia;   Device: PET/CT scanner
2 Recruiting Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms
Conditions: Liver Neoplasms;   Hepatic Cancer;   Liver Cancer
Interventions: Procedure: Thermal Ablation;   Procedure: Standard External Beam Radiation Therapy
3 Recruiting Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer
Conditions: Hepatocellular Cancer;   Liver Cancer
Intervention: Drug: OMP-54F28 with Sorafenib
4 Recruiting Follow-up Yttrium-90 Internal Pair Production PET/CT Imaging in Patients With Primary or Metastatic Liver Tumors as Compared With Brehmsstrahlung Imaging
Conditions: Liver Cancer;   Hepatic Tumors
Intervention: Device: PET/CT Scan
5 Completed Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation
Condition: Liver Neoplasms
Intervention: Drug: perflutren lipid microspheres
6 Recruiting Sorafenib and TRC105 in Hepatocellular Cancer
Conditions: Hepatoma;   Liver Neoplasms;   Adenoma, Liver Cell;   Carcinoma, Hepatocellular
Interventions: Drug: TRC 105;   Drug: Sorafenib
7 Terminated Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors
Condition: Liver Tumors
Intervention: Drug: Definity®
8 Unknown  Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy
Conditions: Hepatoma;   Cinobufacin Injection
Intervention: Drug: Cinobufacin injection
9 Active, not recruiting Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
Condition: Hepatocellular Cancer
Interventions: Drug: Sorafenib;   Procedure: Radiofrequency Ablation
10 Unknown  Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor
Condition: Hepatocellular Cancer
Intervention: Drug: [Met5]-enkephalin (Infusion of opioid growth factor )
11 Unknown  Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors
Condition: Liver Tumors
Intervention: Radiation: Stereotactic Body Radiation Therapy
12 Recruiting Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer
Condition: Hepatocellular Cancer
Intervention: Drug: Tivozanib
13 Active, not recruiting CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer
Conditions: Advanced Hepatocellular Carcinoma;   Liver Cancer;   Hepatic Cancer;   Liver Neoplasms
Interventions: Drug: CS-1008;   Drug: sorafenib
14 Active, not recruiting Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients
Condition: Hepatocellular Cancer
Intervention: Drug: Sorafenib - dose escalation
15 Completed Oxaliplatin in Treating Patients With Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: oxaliplatin;   Other: laboratory biomarker analysis
16 Completed Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors
Conditions: Carcinoma, Hepatocellular;   Liver Neoplasms
Intervention: Device: yttrium Y 90 microspheres (TheraSphere®)
17 Active, not recruiting Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases
Conditions: Hepatocellular Cancer;   Cholangiocarcinoma;   Hepatic Metastases
Intervention: Procedure: Proton Beam Radiation
18 Enrolling by invitation Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option
Conditions: Liver Cancer;   Hepatoma
Intervention: Device: Yttrium 90 (TheraSphere)
19 Withdrawn Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer
Condition: Liver Neoplasms
Intervention: Drug: Temsirolimus 25mg and Pegylated liposomal doxorubicin 25mg/m2
20 Completed
Has Results
Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Biological: bevacizumab;   Drug: erlotinib hydrochloride

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years